Table 6 Clinical class
From: Developing the minimum data set of the corrosive ingestion registry system in Iran
Main Category | Sub-class | Data items |
|---|---|---|
Medical history | Drug and substances consumption history | Drug use, alcohol consumption, smoking cigarette |
Comorbidities | Central nervous system (CNS) diseases, cardiovascular diseases (CVD), pulmonary diseases, GI diseases, hepatic disease, renal diseases, skin diseases, muscle-skeletal diseases, hemorrhagic disorders, endocrine disorders, mental disorders | |
Family history | Mental disorders, drug consumption | |
History of poisoning | Substance name, number of encounters, cause of exposure | |
Poisoning | Corrosive ingestion | Name of ingested substance, the volume of ingestion, physical characteristics of substances, amount of substance, the concentration of a substance, duration time between ingestion until arrival at the hospital, measures taken before and during transportation to a medical center |
Clinical manifestations | CNS manifestations | Coma, delusions, confusion, hallucination, movement disorder, body tremor, myoclonus, level of consciousness, headache, vertigo, convulsions, drowsiness, body temperature changes |
Cardiovascular manifestations | Paroxysmal supraventricular tachycardia (PSVT), extending the QT interval, wide QRS, dysrhythmia, chest pain, blood pressure (BP) disorder, heart rate disorder (tachycardia and bradycardia) | |
GI and liver manifestations | Tenderness, diarrhea, abdominal pain, bloody stools, rebound, reflux or gastritis, GI bleeding, liver problems, abdominal rigidity, burned lips, burning of the oral mucosa, taste change in the mouth, tongue edema, pharynx and larynx edema, erythema of the mucous membranes, mouth ulcers, sialorrhea, dysphagia, nausea | |
Pulmonary manifestations | Airway edema, respiratory rate changes (tachypnea or brady-pnea), aspiration pneumonia, hoarseness, coughing, stertorous, dyspnea, cyanosis, acute lung injury, chemical pneumonitis, wheezing, acute respiratory distress syndrome (ARDS), hemoptysis, crackle, rales | |
Skin and eye manifestations | Facial skin burns, pain at the contact site, burns at the contact site, eczema or rash, angioedema, blister, vesicle, necrosis, abnormal bleeding and bruising, erythema | |
Metabolic status | Increased osmotic gap, increased anion gap, hypoglycemia, metabolic acidosis, metabolic alkalosis | |
Complications | Bleeding, perforation, fistula, esophagus obstruction, mediastinitis, peritonitis, kidney failure, liver dysfunction, hemolysis | |
Diagnosis tests | Laboratory investigations | Atrial blood gases (ABG), white blood cells (WBC), hemoglobin (hb), hematocrit (HCT), platelet count, retic, lactate, blood sugar (BS), base excess, venus blood gaz (VBG), blood urea nitrogen (BUN), creatinine, sodium, potassium, magnesium, anion gap, troponin, ammonia, creatine kinase (CK), creatine phosphokinase (CPK), prothrombin time (PT), partial thromboplastin time (PTT), international normalize ratio (INR), alanine aminotransferase (ALT), aspartate aminotransferase (AST) |
Para-clinical investigations | Endoscopy, X-ray, CT-scan | |
Therapeutic interventions | Supportive treatment | Transfusion blood, intravenous (IV) infusion, gavage, airway management, shock management, Oxygen (O2) therapy, esophageal stent |
Prescription medicine | Steroid, antibiotic, antiacid, analgesics | |
Type of intervention | Gegeostomy feeding, laparotomy, gastrectomy, esophagectomy, colon interposition, gastric polyp surgery, bougienage | |